PCR’s Post

INSIDE LOOK 👀 Read more of the latest research from the upcoming issue (September 9): Is the achievement of sputum culture conversion in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) and cavitary lesions associated with the prognosis? Read the full original research in the September issue to learn more: https://hubs.ly/Q02NR5wG0 #MedEd #JournalCHEST

Sepsis and newly diagnosed Multiple Myeloma (MM): a great risk, associated with poor outcomes. A retrospective study by Desantis V., et al. observed the relationship between clinical conditions, the disease stage, the type of germ involved, and the PFS in this specific cohort of patients. Full: https://buff.ly/4eNblhv #MM #MultipleMyeloma #Sepsis # PFS #NewlyDiagnosed

Learn how our experience and differentiated science is enabling us to design and develop a #CART 2.0 product for autoimmune disease that is scalable and could eliminate or reduce lymphodepletion to meet the unique needs of patients. #celltherapy #immunotherapy   Uncover the Potential of ALLO-329: Allogene.com/Pipeline

⏳ Only a few hours remain till our final webinar! Register now if you haven't done so already: https://lnkd.in/epKv9knb⏳ The webinar will explore the skills required in implementing a step‑wise approach for patients with or at risk of developing #cardiovascular disease, recognising the risk and understanding the management of #hyperkalaemia, and discussing the latest recommendations for additional risk-based therapies in #CKD. #KidneyHealthforAll #ChronicKidneyDisease #CVD KDIGO

Optimize your rare disease studies by planning your integrated evidence generation strategy earlier in development and leveraging modernized study designs. Download our rare disease white paper series to learn more about leveraging RWD and RWE for patient-centric strategies that will help you overcome challenges in rare disease study design and execution. https://hubs.li/Q02mr9LJ0 #PatientsFirst #RareDisease #RWE #RealWorldEvidence #RWD #RealWorldData

Standard of Care can oftentimes be the biggest competitor when it comes to country and site selection. This case study with Bioncle Emas highlights how #TrialHub’s Standard of Care module helped identify the right countries and sites for a Phase 4 rare disease study, and with our real-time insights at their fingertips, they were able to accomplish this 50% faster! Feasibility research is hard, we can help. #feasibility #raredisease #standardofcare https://lnkd.in/grkthsTZ

🔬 Accepted Poster Presentation: Biomed Diagnostics at ASM Microbe 2024 Join us at ASM Microbe 2024, where Biomed Diagnostics, in collaboration with the Centers for Disease Control and Prevention (CDC), will present our latest research. Our study, "Extending Viability Time and Temperature Parameters for InPouch™ TV Trichomonas vaginalis Transportation," offers evidence supporting expanded time and temperature conditions for transporting T. vaginalis. This research suggests modifications to current transportation protocols by demonstrating that T. vaginalis specimens can remain viable under broader time and temperature ranges. These findings aim to provide healthcare providers and laboratories with data to consider more flexible logistical options, potentially enhancing diagnostic accuracy. 📍Read the press release here: https://hubs.ly/Q02wQbG30 #ASMMicrobe2024 #BiomedDiagnostics #CDC #PublicHealth #ScientificResearch #Diagnostics #CultureDiagnostics #InfectiousDisease #SpecimenTransport

Innovative diagnostic tools are reshaping our approach to Sjögren disease, a condition often overlooked in patient care. A promising pilot study showcases a noninvasive eye test that accurately detects meibomian gland dysfunction, potentially expediting diagnosis and treatment. As healthcare marketers, we must highlight the significance of this development and encourage collaboration among specialists to enhance patient outcomes. Embracing evidence-based strategies can drive impactful conversations in healthcare!

Welcome back to Ready, Set, Retina; in this episode, Daniel Epshtein, OD, FAAO, sits down with Carolyn Majcher, OD, FAAO, to discuss how to identify an inherited retinal disease (IRD) on ophthalmic imaging as well as diagnostic and management pearls. #retina #eyecare #ophthalmic #imaging

How can complex innovative designs, meta-analytic predictive models and new statistical approaches help overcome the unique challenges of rare disease clinical trials? Download the latest #SyneosHealth white paper to explore groundbreaking strategies to accelerate the path to effective rare disease treatments: https://lnkd.in/e4e-G9iQ #SyneosHealthLife #WorkHereMattersEverywhere